Photogen


Also found in: Medical.

Pho´to`gen


n.1.(Chem.) A light hydrocarbon oil resembling kerosene. It is obtained by distilling coal, paraffin, etc., and is used as a lubricant, illuminant, etc.
References in periodicals archive ?
f=3&back=1&id=179077477 photogen zanaflex http://www.
Iran and Russia Believe US Global Dominance Expired
In addition, Imagent will be given its best opportunity to achieve success in the marketplace under Photogen, as they will be in position to properly launch the product with the experienced team of professionals that Alliance assembled in San Diego.
PHOTOGEN ACQUIRES ALLIANCE PHARMACEUTICAL'S IMAGING ASSETS
LAJ607) TAFFY WILLIAMS, CEO of PHOTOGEN TECHNOLOGIES INC (PHGN), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward.
TAFFY WILLIAMS - PHOTOGEN TECHNOLOGIES INC (PHGN)
A photograph of Clementina in a dark riding habit and her sister Isabella in an off-the-shoulder white dress shows the two daughters as mirroring images of dark and light, Nycteris and Photogen, masculine and feminine, the object of desire and her pursuer.
Clementina's Daughters
patents, was a co-founder of Photogen Technologies, where he held several senior management positions, and was also a senior research staff member at the Oak Ridge National Laboratory.
Provectus Pharmaceuticals Forms Independent Board to Meet Corporate Governance Requirements
Scott served in senior management positions at Photogen Technologies, Inc.
Provectus President Timothy Scott, Ph.D., Receives 'Distinguished Achievement Award' from University of Wisconsin, Madison, College of Engineering
Dees is an immunologist and molecular biologist who has spent more than 20 years in senior management positions at Photogen Technologies, Inc.
Provectus CEO to Speak at CFA Society of Cleveland Meeting
Provectus' experienced management team, comprised of several leading scientists, developed and own 12 US patents, and are currently seeking approval on 18 patent applications developed through a six-year, $30 million research collaboration with Photogen Technologies, a company founded by senior executives of Provectus.
Provectus Preparing FDA Investigational New Drug (IND) Application On Provecta(TM) for Treatment of Solid Tumors
Valley), a privately held Tennessee corporation, formerly known as Photogen, Inc.
Forum Alert: Provectus Pharmaceuticals Inc. will Present at the Informed Investors Biotechnology / Healthcare / Pharmaceutical Investor Forum at The Princeton Club of New York on Wednesday, June 15, 2005, 12:50 pm ET
Provectus' experienced management team, comprised of several leading scientists, developed and own 12 US patents, and are currently pending approval on 18 patent applications developed through a six-year, $30 million research program in collaboration with Photogen Technologies.
The Research Works Initiates Coverage of Provectus; Equity Research Firm Targets $5.00 Share Price
On January 13, 2004, Photogen received a determination from the Nasdaq Listing Qualifications Panel that Photogen's common stock will continue to be listed on The Nasdaq SmallCap Market via an exception from the annual meeting and proxy solicitation requirements.
Photogen Technologies Receives Nasdaq Notice of Additional Deficiencies
Pink Sheets:ICPH) (formerly known as Photogen Technologies, Inc.
IMCOR Pharmaceutical Co. Announces Departure of CFO
Dictionary browser ?
Full browser ?